Interferon regulatory factor-1 (irf-1) shapes both innate and cd8 + t cell immune responses against west nile virus infection

PLoS Pathogens

Volumn 7, Issue 9, 2011, Pages

  Brien, James D ^a   Daffis, Stephane ^a   Lazear, Helen M ^a   Cho, Hyelim ^a   Suthar, Mehul S ^b   Gale Jr , Michael ^b   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EX VIVO STUDY; FIBROBLAST; FLAVIVIRUS INFECTION; IMMUNOREGULATION; IN VITRO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; WEST NILE FLAVIVIRUS INFECTION; ADAPTIVE IMMUNITY; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; PHYSIOLOGY; WEST NILE FEVER;

ANIMALIA; MUS; WEST NILE VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED C57BL; WEST NILE FEVER; WEST NILE VIRUS;

EID: 80053447769     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002230     Document Type: Article

References (77)

1. Kawai T, Akira S, (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137.
2. Honda K, Taniguchi T, (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658.
3. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
4. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104: 1371-1376.
5. Degols G, Eldin P, Mechti N, (2007) ISG20, an actor of the innate immune response. Biochimie 89: 831-835.
6. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, et al. (2006) PKR and RNAse L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80: 7009-7019.
7. Zhang Y, Burke CW, Ryman KD, Klimstra WB, (2007) Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81: 11246-11255.
8. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
9. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, et al. (2010) 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468: 452-456.
10. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M Jr, et al. (2008) Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82: 8465-8475.
11. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, et al. (2003) Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511-515.
12. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, et al. (2006) West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 12: 395-402.
13. Samuel MA, Diamond MS, (2006) Pathogenesis of West Nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80: 9349-9360.
14. Diamond MS, Mehlhop E, Oliphant T, Samuel MA, (2009) The host immunologic response to West Nile encephalitis virus. Front Biosci 14: 3024-3034.
15. Samuel MA, Diamond MS, (2005) Type I IFN protects against lethal West Nile Virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79: 13350-13361.
16. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, et al. (2006) Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80: 9424-9434.
17. Lazear HM, Pinto AK, Vogt MR, Gale M Jr, Diamond MS, (2011) Interferon-{beta} controls West Nile virus infection and pathogenesis in mice. J Virol 85: 7186-7194.
18. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, et al. (2010) IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6: e1000757.
19. Daffis S, Suthar MS, Szretter KJ, Gale M Jr, Diamond MS, (2009) Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog 5: e1000607.
20. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T, (1989) Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337: 270-272.
21. Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y, et al. (1988) Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. Embo J 7: 3397-3405.
22. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, et al. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54: 903-913.
23. Pine R, (1992) Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol 66: 4470-4478.
24. Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, et al. (2004) Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 78: 9713-9720.
25. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
26. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D, (2010) Gene modulation and immunoregulatory roles of Interferon gamma. Cytokine 50: 1-14.
27. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, et al. (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924.
28. Kollet JI, Petro TM, (2006) IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol Immunol 43: 623-633.
29. Liu J, Cao S, Herman LM, Ma X, (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med 198: 1265-1276.
30. Liu J, Guan X, Ma X, (2005) Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages. J Biol Chem 280: 24347-24355.
31. Vila-del Sol V, Punzon C, Fresno M, (2008) IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181: 4461-4470.
32. Dutia BM, Allen DJ, Dyson H, Nash AA, (1999) Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology 261: 173-179.
33. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C, (1994) Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. Embo J 13: 4798-4806.
34. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, et al. (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839.
35. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, et al. (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259: 968-971.
36. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, et al. (1995) An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599.
37. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, et al. (2002) IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22: 39-47.
38. Tamura T, Yanai H, Savitsky D, Taniguchi T, (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26: 535-584.
39. Penninger JM, Sirard C, Mittrucker HW, Chidgey A, Kozieradzki I, et al. (1997) The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 7: 243-254.
40. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, et al. (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75: 83-97.
41. White LC, Wright KL, Felix NJ, Ruffner H, Reis LF, et al. (1996) Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity 5: 365-376.
42. Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, et al. (1997) Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6: 681-689.
43. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, et al. (1997) Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6: 673-679.
44. Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, et al. (2008) The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat Immunol 9: 34-41.
45. Feng C, Watanabe S, Maruyama S, Suzuki G, Sato M, et al. (1999) An alternate pathway for type 1 T cell differentiation. Int Immunol 11: 1185-1194.
46. Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, et al. (2008) IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J Immunol 181: 1673-1682.
47. Daffis S, Samuel MA, Keller BC, Gale M Jr, Diamond MS, (2007) Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog 3: e106.
48. Ramana CV, Gil MP, Schreiber RD, Stark GR, (2002) Stat1-dependent and-independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23: 96-101.
49. Austin BA, James C, Silverman RH, Carr DJ, (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J Immunol 175: 1100-1106.
50. Rios M, Zhang MJ, Grinev A, Srinivasan K, Daniel S, et al. (2006) Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 46: 659-667.
51. Kong KF, Wang X, Anderson JF, Fikrig E, Montgomery RR, (2008) West nile virus attenuates activation of primary human macrophages. Viral Immunol 21: 78-82.
52. DeWitte-Orr SJ, Collins SE, Bauer CM, Bowdish DM, Mossman KL, (2010) An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog 6: e1000829.
53. Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, et al. (2010) The innate immune adaptor molecule MyD88 restricts West Nile replication and spread in neurons of the central nervous system. J Virol 84: 12125-12138.
54. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
55. Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW, (1985) Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol 134: 1609-1618.
56. Tovey MG, Lallemand C, Thyphronitis G, (2008) Adjuvant activity of type I interferons. Biol Chem 389: 541-545.
57. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586.
58. Shrestha B, Diamond MS, (2004) The role of CD8+ T cells in the control of West Nile virus infection. J Virol 78: 8312-8321.
59. Shrestha B, Diamond MS, (2007) Fas Ligand interactions contribute to CD8+ T cell-mediated control of West Nile virus infection in the central nervous system. J Virol 81: 11749-11757.
60. Shrestha B, Samuel MA, Diamond MS, (2006) CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80: 119-129.
61. Wang Y, Lobigs M, Lee E, Mullbacher A, (2003) CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77: 13323-13334.
62. Brien JD, Uhrlaub JL, Nikolich-Zugich J, (2007) Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37: 1855-1863.
63. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, et al. (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119: 3266-3277.
64. McCandless EE, Zhang B, Diamond MS, Klein RS, (2008) CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci U S A 105: 11270-11275.
65. Platanias LC, (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386.
66. Garcia-Sastre A, Biron CA, (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312: 879-882.
67. Ank N, West H, Paludan SR, (2006) IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26: 373-379.
68. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, et al. (2006) Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 80: 5338-5348.
69. Wang T, Scully E, Yin Z, Kim JH, Wang S, et al. (2003) IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol 171: 2524-2531.
70. Azzam-Smoak K, Noah DL, Stewart MJ, Blum MA, Sherry B, (2002) Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology 298: 20-29.
71. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37: 1845-1854.
72. Ebel GD, Dupuis AP III, Ngo K, Nicholas D, Kauffman E, et al. (2001) Partial genetic characterization of West Nile Virus strains, New York State, 2000. Emerg Inf Dis 7: 650-653.
73. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
74. Mehlhop E, Diamond MS, (2006) Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 203: 1371-1381.
75. Fuchs A, Pinto AK, Schwaeble WJ, Diamond MS, (2011) The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412: 101-109.
76. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, et al. (2009) The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol 83: 9329-9338.
77. Byers AM, Kemball CC, Moser JM, Lukacher AE, (2003) Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 171: 17-21.